Reproduction

Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for PCOS

Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide. A global effort through the International PCOS Network has changed the name of a significant women’s health condition that was misunderstood to be ‘all about ovarian cysts’.

Have your say in the State of Endocrinology 2025 Survey

Calling all clinicians, clinician-scientists and biomedical researchers to complete the 'State of Endocrinology 2025 Survey' - this is your chance to raise your voice!

ISE selects Bioscientifica as its association management provider

Bioscientifica is delighted to announce that it has been selected as the new association management provider for the International Society of Endocrinology (ISE), effective January 2025. This appointment follows a competitive selection process led by the ISE Board.

British Menopause Society issues statement in response to BBC One's Panorama documentary (30 September 2024)

Please read the British Menopause Society statement in response to the BBC One Panorama programme on 30 September 2024.

New research identifies rare genes behind early menopause

New study links Polycystic Ovarian Syndrome (PCOS) to higher risk of eating disorders

A study presented in The Journal of Clinical Endocrinology & Metabolism suggests that women diagnosed with PCOS have a 53% higher risk of developing an eating disorder, especially bulimia nervosa or binge eating disorder, than women without PCOS. The study concludes that more research is needed.

Medscape

Sudden unexpected infant death (SUID) risk may be linked to maternal obesity

Fertility and neonatal outcomes not associated with primary hyperparathyroidism

Study suggests gender bias in lab research affects health outcomes in women